Position in TNYA
as of Mar 31, 2026
· filed Apr 8, 2026
Position Value
$613,746
+$198,989 QoQ
Shares Held
886,917
+52.3% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#19
of 103 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mirador Capital Partners LP holds $24,062,902 across 5 Biotechnology names. TNYA ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
202,673 | $13,358,177 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
178,053 | $5,647,841 | |
| 3 | IOVA |
Iovance Biotherapeutics, Inc.
|
1,073,236 | $3,767,058 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
4,000 | $676,080 | |
| 5 | TNYA |
Tenaya Therapeutics, Inc.
This page
|
886,917 | $613,746 |
All Filings in TNYA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $613,746 | 886,917 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $414,757 | 582,524 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $38,070 | 23,500 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $10,387 | 17,000 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $8,550 | 15,000 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||